The treatment landscape for Global Lambert-Eaton Myasthenic Syndrome (LEMS) is dynamically changing. While there is no cure present, a variety of treatment options are available to alleviate symptoms and improve quality of life. Popular therapies include immunomodulatory drugs, aimed at modulating the autoimmune response. In lately, there has been